Q3 2017 Holdings
Filed 2018-03-02 | 56 holdings | $45.8M | 13F-HR | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↓ | Shares | % Portfolio |
|---|---|---|---|---|---|
| Biogen Inc(BIIB) | COM | 09062X103 | $22.4M | 71,508 | 48.9% |
| Acadia Pharmaceuticals Inc(ACAD) | COM | 004225108 | $9.1M | 240,773 | 19.8% |
| Biomarin Pharmaceutical Inc(BMRN) | COM | 09061G101 | $6.4M | 68,384 | 13.9% |
| Alynylam Pharmaceuticals Inc(ALNY) | COM | 02043Q107 | $4.9M | 41,300 | 10.6% |
| Corcept Therapeutics Inc(CORT) | COM | 218352102 | $1.6M | 83,000 | 3.5% |
| Agios Pharmaceuticals Inc(AGIO) | COM | 00847X104 | $1.3M | 20,000 | 2.9% |
| Celgene Corp(CELG) | COM | 151020104 | $26.3K | 180,522 | 0.1% |
| Regeneron Pharmaceuticals(REGN) | COM | 75886F107 | $18.3K | 40,830 | 0.0% |
| Vertex Pharmaceuticals Inc(VRTX) | COM | 92532F100 | $13.5K | 88,722 | 0.0% |
| Alexion Pharmaceuticals Inc(ALXN) | COM | 015351109 | $12.9K | 92,141 | 0.0% |
| Incyte Corp(INCY) | COM | 45337C102 | $10.4K | 88,975 | 0.0% |
| Gilead Sciences Inc(GILD) | COM | 375558103 | $9.9K | 122,784 | 0.0% |
| Adamas Pharmaceuticals Inc(ADMSEUR) | COM | 00548A106 | $8.3K | 390,000 | 0.0% |
| Amgen Inc(AMGN) | COM | 031162100 | $6.7K | 36,104 | 0.0% |
| Entellus MED Inc | COM | 29363K105 | $6.3K | 341,468 | 0.0% |
| Exelixis Inc(EXEL) | COM | 30161Q104 | $6.2K | 254,334 | 0.0% |
| Acceleron Pharma Inc(XLRN) | COM | 00434H108 | $5.7K | 153,633 | 0.0% |
| Sarepta Therapeutics Inc(SRPT) | COM | 803607100 | $5.5K | 121,000 | 0.0% |
| Paratek Pharmaceuticals Inc | COM | 699374302 | $5.1K | 202,000 | 0.0% |
| Halozyme Therapeutics Inc(HALO) | COM | 40637H109 | $4.9K | 282,633 | 0.0% |
| Clovis Oncology Inc(CLVSEUR) | COM | 189464100 | $4.6K | 56,000 | 0.0% |
| Tesaro Inc | COM | 881569107 | $4.5K | 35,000 | 0.0% |
| Sangamo Therapeutics Inc(SGMO) | COM | 800677106 | $4.1K | 273,000 | 0.0% |
| Neurocrine Biosciences Inc(NBIX) | COM | 64125C109 | $4.0K | 66,000 | 0.0% |
| Ligand Pharmaceuticals Inc(LGND) | COM | 53220K504 | $3.9K | 29,000 | 0.0% |
| Five Prime Therapeutics Inc(FPRX) | COM | 33830X104 | $3.5K | 86,500 | 0.0% |
| Seattle Genetics Inc | COM | 812578102 | $3.1K | 57,500 | 0.0% |
| Array Biopharma Inc(ARRYEUR) | COM | 04269X105 | $3.0K | 247,500 | 0.0% |
| Calithera Biosciences(CALAEUR) | COM | 13089P101 | $3.0K | 188,000 | 0.0% |
| Dermira Inc(DERMEUR) | COM | 24983L104 | $2.9K | 108,000 | 0.0% |
| Juno Therapeutics Inc | COM | 48205A109 | $2.8K | 63,000 | 0.0% |
| Synergy Pharmaceuticals del | COM | 871639308 | $2.8K | 971,922 | 0.0% |
| Bluebird BIO Inc | COM | 09609G100 | $2.7K | 20,000 | 0.0% |
| Ionis Pharmaceutical Inc(IONS) | COM | 462222100 | $2.6K | 51,500 | 0.0% |
| Kalvista Pharmaceuticals Inc(KALV) | COM | 483497103 | $2.1K | 322,436 | 0.0% |
| Stemline Therapeutics Inc | COM | 85858C107 | $2.0K | 182,930 | 0.0% |
| Fibrogen Inc(FGENEUR) | COM | 31572Q808 | $1.7K | 31,400 | 0.0% |
| Avexis Inc | COM | 05366U100 | $1.6K | 17,000 | 0.0% |
| Veracyte Inc(VCYT) | COM | 92337F107 | $1.5K | 170,000 | 0.0% |
| Omeros Corp(OMER) | COM | 682143102 | $1.3K | 61,000 | 0.0% |
| Portola Pharmaceuticals Inc | COM | 737010108 | $1.3K | 24,000 | 0.0% |
| Transenterix Inc | COM | 89366M201 | $1.3K | 889,082 | 0.0% |
| Achaogen Inc | COM | 004449104 | $1.2K | 74,538 | 0.0% |
| Spark Therapeutics Inc | COM | 84652J103 | $1.1K | 12,000 | 0.0% |
| Sage Therapeutics Inc(SG7) | COM | 78667J108 | $1.1K | 16,996 | 0.0% |
| G1 Therapeutics Inc(GTHXEUR) | COM | 3621LQ109 | $971 | 39,000 | 0.0% |
| Ironwood Pharmaceuticals Inc(IRWD) | COM CLA | 46333X108 | $930 | 59,000 | 0.0% |
| Amicus Therapeutics Inc(FOLD) | COM | 03152W109 | $883 | 58,600 | 0.0% |
| Horizon Pharma PLC | SHS | G4617B105 | $876 | 69,000 | 0.0% |
| Supernus Pharmaceuticals Inc(SUPN) | COM | 868459108 | $838 | 20,953 | 0.0% |